share_log

Reported Earlier, Nona Biosciences Enters Global License Agreement With AstraZeneca For Monoclonal Antibody Development

Benzinga ·  May 23 15:13
Reported Earlier, Nona Biosciences Enters Global License Agreement With AstraZeneca For Monoclonal Antibody Development
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment